User login

Enter your username and password here in order to log in on the website:

Forgot your password?

Press releases

07.06.2019

Regulatory Announcement: SYNLAB to launch a debt refinancing transaction aiming at proceeds of up to €920,000,000

SYNLAB Bondco Plc ("SYNLAB") today announced that it is preparing the launch of a debt refinancing transaction aiming to raise up to an aggregate principal amount of €920,000,000 through a term loan facility, maturing in 2026 ... 

09.04.2019

SYNLAB has successfully raised EUR 150 million through an add-on to its existing Term Loan Facility.

SYNLAB Bondco Plc (»SYNLAB« or »the Group«), the leading provider of medical diagnostic services in Europe, today announced that it successfully raised EUR 150 million of incremental debt on its existing Term Loan Facility, ... 

10.10.2018

SYNLAB Founding Member of Global Diagnostics Network (GDN) – Combined Excellence in a Worldwide Community for Laboratory Diagnostics

The GDN, initiated by US-based Quest Diagnostics, brings together leading diagnostics services providers to share expertise and insights and drive worldwide diagnostics innovation 

13.07.2018

SYNLAB acquires leading Finnish laboratory services provider Yhtyneet Medix Laboratoriot Oy

SYNLAB ("SYNLAB" and “the Group”), the leading medical diagnostic services provider in Europe, announces that the Group acquired 100% of the shares in Yhtyneet Medix Laboratoriot Oy (“YML”), Finland’s leading private laboratory ... 

10.01.2018

Dr Bartl Wimmer to retire as SYNLAB Group CEO in April 2018 Deputy CEO Mathieu Floreani to succeed as Group CEO from 2 April 2018

Munich, 10 January 2018 – SYNLAB Group (‘SYNLAB’ or ‘the Group’) the leading European provider of medical diagnostic services, today announces that Dr Bartl Wimmer will retire as Group Chief Executive Officer with effect from 2 ... 

10.01.2018

Regulatory Announcement: Dr Bartl Wimmer to retire as SYNLAB Group CEO in April 2018 Deputy CEO Mathieu Floreani to succeed as Group CEO from 2 April 2018

Munich, 10 January 2018 – SYNLAB Group (‘SYNLAB’ or ‘the Group’) the leading European provider of medical diagnostic services, today announces that Dr Bartl Wimmer will retire as Group Chief Executive Officer with effect from 2 ... 

13.09.2017

SYNLAB successfully closed a EUR 300 million term loan transaction

SYNLAB Bondco Plc ("SYNLAB" or “the Group”), the leading provider of medical diagnostic services in Europe, today announced that it successfully closed a term loan transaction amounting to EUR 300 million, maturing in 2022. 

08.09.2017

SYNLAB appoints new CBO to steer development in next phase of growth

New Chief Business Officer role reflects the need for SYNLAB to address the challenges brought about by the Group’s sustained growth across geographic regions and the increased scope of the businessSYNLAB Group CEO Wimmer: ... 

29.08.2017

Regulatory Announcement: SYNLAB to launch a term loan transaction

SYNLAB Bondco Plc ("SYNLAB") today announced that it will launch a financing transaction aiming to raise up to a total aggregate principal amount of €300,000,000 through a term loan facility, maturing 2022 (the ... 

10.07.2017

SYNLAB acquires Finnish diagnostic services provider Cityterveys

Acquisition of Cityterveys allows SYNLAB to become one of the largest independent integrated diagnostic services provider in Finland. Munich, 10 July 2017 – SYNLAB Limited ("SYNLAB" and “the Group”), the leading medical ...